| Preview | Issue Date | Title / Name | Author(s) | Type |
| 2018 | Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line setting | Conduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et al | Conference Paper | |
| Nov-2020 | Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer | Collins, Ian M.; Kanjanapan, Yada; Wen Lok, Sheau; Gibbs, Peter; De Boer, Richard, et al | Journal Article | |
| 2018 | Management of brainmetastases in patients with HER2 positive breast cancer-a real world Australian experience | Moldovan, Cristina A.; King, Rossa; Lok, Sheau Wen; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| 2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer | Conduit, C.; de Boer, R. H.; Lok, S.; Gibbs, Peter; Malik, Laeeq, et al | Journal Article | |
| Oct-2022 | Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Yeo, Belinda, et al | Journal Article | |
| 2021 | Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |
| 2017 | Tumour Characteristics and Treatment Patterns in Relapsed Metastatic HER2 Positive Breast Cancer | Yip, Desmond; Lok, Sheau Wen; Gibbs, Peter; Lombard, Janine; Richardson, Gary, et al | Conference Paper | |
